Essential Reviews in Geriatric Psychiatry
Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials
Publication
, Chapter
Kim, S; Holsinger, T
January 1, 2022
In this meta-analysis, the investigators reviewed the use of antipsychotics for treating behavioral and psychological symptoms in dementia (BPSD) and the potential side effect of decline in cognitive function from ten randomized placebo-controlled trials (RCTs).
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Kim, S., & Holsinger, T. (2022). Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials. In Essential Reviews in Geriatric Psychiatry (pp. 29–33). https://doi.org/10.1007/978-3-030-94960-0_5
Kim, S., and T. Holsinger. “Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials.” In Essential Reviews in Geriatric Psychiatry, 29–33, 2022. https://doi.org/10.1007/978-3-030-94960-0_5.
Kim S, Holsinger T. Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials. In: Essential Reviews in Geriatric Psychiatry. 2022. p. 29–33.
Kim, S., and T. Holsinger. “Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials.” Essential Reviews in Geriatric Psychiatry, 2022, pp. 29–33. Scopus, doi:10.1007/978-3-030-94960-0_5.
Kim S, Holsinger T. Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials. Essential Reviews in Geriatric Psychiatry. 2022. p. 29–33.